Therapeutic options of chronic hepatitis B Waldemar Halota, Małgorzata Pawłowska Medical Science Review - Hepatologia 2005; 5 91-94 aaICID: 16120
IC™ Value: 1.86
Abstract provided by Publisher
Katedra i Klinika Chorób Zakaźnych i Hepatologii CM UMK w Bydgoszczy
Recognition of HBV life cycle and immunological mechanisms connected with this infection there are a reason for evolving a better therapeutic options. The authors present recent date on new therapies with the potential to improve clinical response, delay disease progression and enhance long-term therapeutic outcomes in patients with chronic hepatitis B.